HARBIN, China, August 13, 2014 /PRNewswire/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages and organic and specialty foods, today announced its results for the three months and six months ended June 30, 2014.
Financial Highlights for the Three Months Ended June 30, 2014
Financial Highlights for the Six Months Ended June 30, 2014
Management Commentary
Ms. Lianyun Han, CEO of Nutrastar, commented, "Our entire consumer product portfolio performed in line with expectations in the three month period ended June 30, 2014. Sales of our core premium consumer product Cordyceps came in at an impressive $10.69 million, up 21.5% year-over-year. This included approximately $1.0 million in sales of our new Cordyceps powder solution product, which was initially distributed within our current specialty nutraceuticals stores channels located in Harbin as a part of its testing phase. Sales of our 210ml and 310ml beverage offerings closed at $1.75 million, down 31.0% year-over-year due to the product line realignment to meet the market demand. Organic and specialty foods segment, our third consumer product category, experienced sales growth of 4.1%, contributing $0.56 million to revenues."
Ms. Han continued, "Overall, we're delighted with the outcome of the second quarter and first six months of the year - both periods marked by continued strong margins and an overall increase in revenue thanks to continued Cordyceps demand and the introduction of our new soluble, powder solution product. This synergistic soluble on-the-go Cordyceps product we believe has the potential to take Nutrastar to the next level - the international market - which we are extremely excited about. In terms of strategy, we were fortunate to bring on Beijing Meilitianhe Fortune Investment Management Co., Ltd. ("MLTH") as a strategic investor through a private share transaction in late June. This development not only further diversified management's holdings, but also aided us in expanding our reach and opportunity in China. MLTH has been instrumental in introducing and helping us secure our first distributor in Hubei for the new Cordyceps powder solution product, and are confident there will be more opportunities like this coming our way."
"As it stands now, we remain the single largest producer of commercially cultivated Cordyceps Militaris. Continued Cordyceps demand coupled with the introduction of exciting products and a broadening in our geographical reach will facilitate future expansion and allow us to achieve key milestones set forth in our long-term growth plan including extending our market presence well-beyond China. We will keep the public and shareholders apprised of our development progress with these initiatives and in all other areas of our business as we are able to, and encourage any interested party to reach out directly for more information on the Company and our innovative, premium consumer product portfolio," added Ms. Han.
Outlook for the Year Ending December 31, 2014
Based on management's current expectations, full year 2014 revenue should fall in the range of $47 million to $50 million, representing an approximate 8% to 15% year-over-year top line growth.
Request for Call with Management
Investors are invited to request a call with Nutrastar's management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.
For more information regarding Nutrastar's financial performance during the three and six months ended June 30, 2014, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on or about August 13, 2014.
About Nutrastar International Inc.
Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 330 employees, including 21 in R&D, and 149 in sales and marketing. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrastarintl.com
Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts
Safe Harbor Statement
This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
Richard Hull
American Capital Ventures
Tel: +1-305-918-7000
Email: rh@amcapventures.com
NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES | ||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME | ||||||||||||
(Unaudited) | ||||||||||||
(AMOUNTS EXPRESSED IN US DOLLARS) | ||||||||||||
For the Three Months | For the Six Months | |||||||||||
Ended June 30, | Ended June 30, | |||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||
NET REVENUE | $ | 13,004,562 | $ | 11,874,334 | $ | 19,871,243 | $ | 19,285,470 | ||||
Cost of goods sold | (2,953,060) | (2,731,416) | (4,581,314) | (4,503,704) | ||||||||
GROSS PROFIT | 10,051,502 | 9,142,918 | 15,289,929 | 14,781,766 | ||||||||
Selling expenses | (478,832) | (473,793) | (725,895) | (904,256) | ||||||||
General and administrative expenses | (533,618) | (696,752) | (1,206,633) | (1,289,267) | ||||||||
Income from operations | 9,039,052 | 7,972,373 | 13,357,401 | 12,588,243 | ||||||||
Other income (expenses): | ||||||||||||
Interest income | 97,226 | 78,748 | 189,084 | 162,489 | ||||||||
Foreign exchange differences | (1,639) | 31,644 | (19,728) | 26,457 | ||||||||
Change in fair value of warrants | - | 173 | - | 173 | ||||||||
Total other income | 95,587 | 110,565 | 169,356 | 189,119 | ||||||||
Income before income taxes | 9,134,639 | 8,082,938 | 13,526,757 | 12,777,362 | ||||||||
Provision for income taxes | (2,338,917) | (2,120,129) | (3,497,461) | (3,399,869) | ||||||||
NET INCOME | 6,795,722 | 5,962,809 | 10,029,296 | 9,377,493 | ||||||||
OTHER COMPREHENSIVE INCOME: | ||||||||||||
Foreign currency translation adjustments | (17,913) | 1,389,545 | (1,070,742) | 1,629,292 | ||||||||
COMPREHENSIVE INCOME | $ | 6,777,809 | $ | 7,352,354 | $ | 8,958,554 | $ | 11,006,785 | ||||
Earnings per share: | ||||||||||||
Basic | $ | 0.40 | $ | 0.37 | $ | 0.59 | $ | 0.58 | ||||
Diluted | $ | 0.38 | $ | 0.35 | $ | 0.57 | $ | 0.55 | ||||
Weighted average number of shares outstanding: | ||||||||||||
Basic | 16,858,667 | 15,863,826 | 16,758,599 | 15,863,826 | ||||||||
Diluted | 17,694,270 | 16,993,926 | 17,657,471 | 16,993,926 | ||||||||
NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES | ||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
(AMOUNTS EXPRESSED IN US DOLLARS) | ||||||
June 30, 2014 | December 31, 2013 | |||||
(Unaudited) | ||||||
ASSETS | ||||||
CURRENT ASSETS | ||||||
Cash and cash equivalents | $ | 112,323,274 | $ | 102,599,186 | ||
Accounts receivable | 93,688 | 56,922 | ||||
Inventories | 821,897 | 691,847 | ||||
Prepayments and other receivables | 1,356,424 | 1,300,012 | ||||
Total current assets | 114,595,283 | 104,647,967 | ||||
OTHER ASSETS | ||||||
Intangible assets, net | 853,809 | 1,107,737 | ||||
Property, plant and equipment, net | 14,843,123 | 15,481,249 | ||||
Total assets | $ | 130,292,215 | $ | 121,236,953 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
CURRENT LIABILITIES | ||||||
Other payables and accruals | $ | 1,030,344 | $ | 1,167,957 | ||
Taxes payable | 2,806,214 | 2,879,172 | ||||
Due to a related party | 452,668 | 265,223 | ||||
Preferred stock dividend payable | 604,666 | 738,903 | ||||
Total current liabilities | 4,893,892 | 5,051,255 | ||||
Total liabilities | 4,893,892 | 5,051,255 | ||||
COMMITMENTS AND CONTINGENCIES | ||||||
STOCKHOLDERS' EQUITY | ||||||
Preferred Stock, $0.001 par value,1,000,000 shares authorized, 77,776 | 1,773,772 | 2,510,183 | ||||
Common stock, $0.001 par value, 190,000,000 shares authorized, 16,908,541 | 16,909 | 16,422 | ||||
Additional paid-in capital | 21,012,795 | 19,934,551 | ||||
Statutory reserves | 4,989,036 | 4,983,935 | ||||
Treasury stock, at cost, 43,555 shares | (78,767) | (78,767) | ||||
Retained earnings | 90,178,823 | 80,242,877 | ||||
Accumulated other comprehensive income | 7,505,755 | 8,576,497 | ||||
Total stockholders' equity | 125,398,323 | 116,185,698 | ||||
Total liabilities and stockholders' equity | $ | 130,292,215 | $ | 121,236,953 | ||
| ||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||
(Unaudited) | ||||||
(AMOUNTS EXPRESSED IN US DOLLARS) | ||||||
For the Six Months Ended | ||||||
2014 | 2013 | |||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||
Net income | $ | 10,029,296 | $ | 9,377,493 | ||
Adjustments to reconcile net income to cash provided by operating activities: | ||||||
Change in fair value of warrants | - | (173) | ||||
Consultant restricted stock expense | 53,371 | - | ||||
Depreciation and amortization | 743,052 | 731,128 | ||||
Share-based compensation expense | 66,463 | 108,613 | ||||
(Increase) decrease in assets: | ||||||
Accounts receivable | (37,370) | (8,537) | ||||
Inventories | (136,651) | (265,896) | ||||
Prepayments and other receivables | (68,381) | 885,634 | ||||
Increase (decrease) in liabilities: | ||||||
Other payables and accruals | (127,833) | 305,355 | ||||
Advance from related party | 179,980 | - | ||||
Taxes payable | (46,908) | (197,651) | ||||
Net cash provided by operating activities | 10,655,019 | 10,935,966 | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||
Advance from/(Repayment to) related party | 29,704 | (27,009) | ||||
Net cash provided by/(used in) financing activities | 29,704 | (27,009) | ||||
Foreign currency translation adjustment | (960,635) | 1,412,437 | ||||
INCREASE IN CASH AND CASH EQUIVALENTS | 9,724,088 | 12,321,394 | ||||
CASH AND CASH EQUIVALENTS, at the beginning of the period | 102,599,186 | 75,526,533 | ||||
CASH AND CASH EQUIVALENTS, at the end of the period | $ | 112,323,274 | $ | 87,847,927 | ||
NON-CASH TRANSACTIONS | ||||||
Preferred stock and dividend converted into common stock | $ | 958,897 | $ | - | ||
Preferred stock dividend payable | 88,249 | 112,246 | ||||
Share-based payment to officers and directors under equity incentive plan | 66,463 | 108,613 | ||||
Share-based payment - IR warrants | 53,371 | - | ||||
SUPPLEMENTAL DISCLOSURE INFORMATION | ||||||
Income taxes paid | $ | 3,502,450 | $ | 3,468,821 | ||
